ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1418	National Cancer Institute	Html	en	Cancer-Related Post-traumatic Stress (PDQ®)–Patient Version	Shock, fear, helplessness, or horror can be felt by cancer patients at any time and lead to cancer-related post-traumatic stress. Learn about the causes and ways doctors can help manage these symptoms of distress in this expert-reviewed summary.	cancer treatment 0.338437 life-threatening stress 0.303648 natural disasters 0.295492 PDQ cancer information 0.517368 upsetting event 0.305231 clinical trial search 0.288109 certain triggers 0.298605 stressful events 0.297941 clinical trials 0.416557 cancer information summary 0.420357 clinical trial 0.342943 breast cancer prevention 0.304611 PDQ summaries 0.31577 patients 0.413744 cancer patients 0.39239 latest published information 0.297252 childhood cancer survivors 0.334732 cancer-related PTS 0.301933 NCI’s PDQ 0.315928 NCI PDQ cancer 0.384736 cancer survivors 0.382895 violent personal attack 0.28851 cancer-related post-traumatic stress 0.771546 Breast cancer survivors 0.324986	treatment 0.388516 post-traumatic stress disorder 0.44428 cancer prevention 0.308777 cancer experience 0.306174 anxiety disorders 0.288817 Cancer Information Service 0.325795 PDQ Supportive 0.310148 treatment clinical trials 0.303343 National Cancer Institute 0.448327 post-traumatic stress symptoms 0.498161 PDQ documents 0.307297 early symptoms 0.28734 Palliative Care Editorial 0.346292 new treatment 0.299459 possible cancer recurrence 0.324764 PDQ database 0.313308 Cancer Care page 0.31311 Care Editorial Board 0.347322 PDQ summary 0.393635 PTSD 0.349898 PTSD). 0.290236 cancer clinical trials 0.330243 cancer information summaries 0.334057 comprehensive cancer information 0.334182	CLICK HERE
1491	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	Elective neck radiation 0.612858 locally advanced head 0.629434 radiation therapy-based treatment 0.65069 randomized controlled trials 0.580539 Engl J Med 0.592068 advanced laryngeal cancer 0.614525 radiation therapy. 0.583072 Laryngeal Cancer Study 0.614831 laryngeal cancer 0.719655 Int J Radiat 0.605237 randomized study 0.574463 Radiation Therapy Oncology 0.613999 neck cancer patients 0.594571 Radiat Oncol Biol 0.689017 induction chemotherapy group 0.591432 patients 0.718736 initial radiation 0.58218 standard treatment options 0.574341 lymph nodes 0.592104 early-stage larynx cancer 0.642059 radiation therapy 0.991511 beam radiation therapy 0.610314 et al. 0.672465 concomitant chemotherapy 0.657903	larynx cancer 0.643614 Affairs Laryngeal Cancer 0.575648 radiation failures 0.582504 altered fractionation radiation 0.602814 intensity-modulated radiation therapy 0.607841 laryngeal cancers 0.598434 Concurrent radiation therapy 0.626365 advanced larynx cancer 0.579933 radiation field 0.584791 high local control 0.57619 definitive radiation therapy 0.62584 local control 0.651065 external-beam radiation therapy 0.622106 early-stage laryngeal cancer 0.582781 Oncol Biol Phys 0.693462 lymph node involvement 0.5855 particle-beam radiation therapy 0.628769 neck cancer 0.66828 lymph node 0.614894 treatment options 0.588529 local progression-free survival 0.574463 induction chemotherapy 0.734401 Cancer Study Group 0.595423 squamous cell carcinoma 0.619401	CLICK HERE
1755	National Cancer Institute	Html	en	Genetic Testing for Hereditary Cancer Syndromes	A fact sheet about genetic testing for inherited cancer risk. Includes types of tests, who should consider testing, and how to understand test results.	negative test result 0.400337 health care provider 0.502328 genetic mutation 0.416497 family member 0.418619 harmful genetic mutation 0.411753 cancer-predisposing mutation 0.409751 hereditary cancer disorders 0.398762 hereditary cancer syndromes 0.681889 cancer risk condition 0.40678 health care providers 0.394471 hereditary cancer syndrome 0.621674 family members 0.522464 test results 0.569131 major hereditary cancer 0.393709 possible cancer risk 0.406537 certain hereditary cancer 0.433421 cancer types 0.481189 DTC genetic tests 0.42978 person 0.492341 Genetic Information Nondiscrimination 0.390123 genetic tests 0.554486 specific genetic change 0.3911 specific cancer type 0.391368 genetic counselor 0.453074 male breast cancer 0.389105	DTC genetic testing 0.513411 genetic counseling 0.415519 disease-related genetic mutation 0.41195 family medical history 0.39883 positive test result 0.403147 common inherited cancer 0.408932 particular genetic test 0.407943 inherited genetic variants 0.392436 genetic information 0.399804 health care 0.626411 genetic test results 0.557316 genetic change 0.403267 at-home genetic testing 0.430532 prenatal genetic test 0.402782 genetic mutations 0.44962 breast cancer 0.417779 Hereditary breast cancer 0.406679 people 0.398079 health care decisions 0.427407 genetic testing 0.952895 cancer risk 0.555583 hereditary cancer 0.711991 cancer 0.86681 information 0.408541	CLICK HERE
1769	National Cancer Institute	Html	es	Humo de tabaco en el ambiente y el cáncer	Hoja informativa que resume los estudios sobre los efectos para la salud de la exposición al humo de tabaco en el ambiente.	Protección Ambiental 0.571939 única forma 0.552366 organiza reuniones 0.546237 vías respiratorias 0.568775	Estados Unidos 0.886156 Healthy People 0.776058 ambiente causa 0.925234 programa nacional 0.64248	CLICK HERE
1818	National Cancer Institute	Html	es	Tratamiento del cáncer de paratiroides (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de paratiroides.	Parathyroid carcinoma versus 0.314395 Lippincott Williams 0.313221 interdisciplinary management 0.305907 Lumachi F 0.309431 carcinoma with tc-99m 0.305998 Functioning parathyroid carcinoma 0.307209 Favia G 0.309942 American Cancer Society 0.316114 Cancer Data Base 0.316291 metastasis from parathyroid 0.30974 postoperative parathyroid carcinoma 0.307215 Fleming ID 0.306345 Hundahl SA 0.306222 Data Base Report 0.311266 DeVita VT Jr 0.324372 Radiat Oncol Biol 0.307199 glándulas paratiroides 0.306363 from parathyroid carcinoma 0.319948 parathyroid tumors 0.321669 Clinical review 0.314388 parathyroid carcinoma 0.98314 Prognostic factors 0.306954 Sandelin K 0.34021 metastatic parathyroid carcinoma 0.313321 Bondeson L 0.30997	Rosenberg SA 0.31229 Clin Endocrinol Metab 0.394458 Lawrence TS 0.312691 National Cancer 0.333111 parathyroid carcinoma with 0.31437 parathyroid adenoma 0.30731 Bilezikian JP 0.306387 carcinoma paratiroideo 0.32174 National Cancer Database 0.307384 primary hyperparathyroidism 0.309819 Surg Oncol 0.319122 Busaidy NL 0.306079 National Cancer Data 0.316413 carcinoma versus parathyroid 0.314395 Fremgen AM 0.306349 Auer G 0.3065 9th ed 0.313566 pulmonary metastasis from 0.306768 Kebebew E 0.312769 Oncol Biol Phys 0.30731 Surgeons Commission 0.306833 Princess Margaret Hospital 0.306413 recurrent parathyroid carcinoma 0.307247 parathyroid carcinoma treated 0.330169	CLICK HERE
1862	National Cancer Institute	Html	es	Tratamiento del cáncer de uretra (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de uretra.	urethral tumors 0.342422 secciones distal 0.323073 Lippincott Williams 0.35647 Lin DW 0.322871 papillomaviruses with carcinomas 0.32226 transitional cell carcinoma 0.357652 Ta Carcinoma 0.32924 Gomella LG 0.359219 urethral tumor involvement 0.329567 7th ed 0.322172 Coordinated chemoradiation therapy 0.336249 Instituto Nacional 0.32668 DeVita VT Jr 0.40337 urethra with chemotherapy 0.34093 chemoradiation therapy with 0.337618 Karnes RJ 0.33747 plus infusional high 0.33117 Porter MP 0.322353 Rosenberg SA 0.353321 Male urethral carcinoma 0.339582 Breau RH 0.33767 tercio distal 0.368197 Lawrence TS 0.353966 urethral carcinoma 0.638147 United States 0.321915	End Results 0.324443 Urol Clin North 0.656789 Koontz BF 0.336415 primary urethral carcinoma 0.381596 lesiones tis 0.323889 Cancer Staging Manual 0.353458 lesiones t3 0.324367 radiation oncology 0.341092 lesiones t1 0.339652 Female urethral carcinoma 0.338979 primary invasive carcinoma 0.362458 Lee WR 0.334415 uretra distal 0.976805 Swartz MA 0.321742 9th ed 0.357004 Clin North Am 0.654236 Successful treatment 0.323556 numerosas glándulas 0.322763 Lightner DJ 0.335736 tis pd carcinoma 0.335113 Zhang ZF 0.322598 Tis Carcinoma 0.330085 metastatic urothelial carcinoma 0.358216 AJCC Cancer Staging 0.35514	CLICK HERE
1896	National Cancer Institute	Html	es	Tratamiento del cáncer de páncreas (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de páncreas.	estadio lV 0.425648 pequeñas incisiones 0.367032 aguja fina 0.488715 siguientes procedimientos 0.412593 Estadio IA 0.426998 estadio iv 0.507764 siguientes aspectos 0.382876 Ecografía abdominal 0.386812 estadio ii 0.546166 células endocrinas 0.43128 causa ictericia 0.369929 estadios ia 0.357173 siguientes tipos 0.356896 Estadio IIA 0.42546 rayos x 0.367548 enlace drugs approved 0.5669 melanoma familiar atípico 0.436475 ondas sonoras 0.371814 cercanos.ampliar cáncer 0.946814 tumores neuroendocrinos 0.380539 National Cancer Institute 0.355543 estadio lB 0.430806 tejidos cercanos.ampliar cáncer 0.74829	endocrina múltiple tipo 0.4367 Instituto Nacional 0.397986 estadios iia 0.360412 PDQ Tratamiento 0.883614 presente sumario 0.428926 oculto detrás 0.371225 antecedentes familiares 0.366146 Colangiopancreatografía retrógrada 0.374947 Elabora hormonas 0.377934 estadio llA 0.424706 explorador tep 0.376314 Pancreatectomía distal 0.35778 Physician Data Query 0.499092 Pancreatic Cancer 0.442415 enzimas pancreáticas 0.350126 estadio iii 0.513007 Cirugía paliativa 0.414657 antígeno carcinoembrionario 0.380177 von hippel-lindau 0.376964 ovario hereditario 0.376013 linfáticos cercanos.ampliar cáncer 0.783386 siguientes pruebas 0.38409	CLICK HERE
1904	National Cancer Institute	Html	es	Tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo.	siguientes procedimientos 0.423688 quimioterapia ip 0.416839 estadios ii 0.409427 siguientes aspectos 0.416771 causa hinchazón 0.412974 Ecografía abdominal 0.413715 rayos x 0.41264 estadio ic 0.511392 estadio ivb 0.503452 estadio ib 0.512383 estadio ia 0.511445 enlace drugs approved 0.449365 Fallopian Tube 0.428306 ondas sonoras 0.413458 estadio iva 0.501667 National Cancer Institute 0.410523 Primary Peritoneal Cancer 0.449696 siguientes riesgos 0.40878 realidad células 0.424697 siguientes tratamientos 0.411661 Instituto Nacional 0.43725 estadio iiia 0.506125	PDQ Tratamiento 0.420853 estadio iiic 0.505194 ganglios linfáticos detrás 0.603433 estadio iiib 0.505868 estadio iia 0.510869 estadio iib 0.511005 Physician Data Query 0.437199 or primary peritoneal 0.450381 estadio iii 0.551718 peritoneo causa efectos 0.460442 siguientes situaciones 0.416252 cuello uterino 0.944087 ovario.ampliar anatomía 0.415019 PDQ Prevención 0.426006 histerectomía laparoscópica total.Ampliar 0.422039 siguientes enlaces 0.409849 ecografía transvaginal.Ampliar 0.413879 histerectomía abdominal 0.414317 genes brca1 0.412481 siguientes sumarios 0.425477 siguientes pruebas 0.420302	CLICK HERE
1969	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.	estadio lV 0.482165 siguientes procedimientos 0.954883 estadio iv 0.615433 siguientes elementos 0.511302 Neurofibromatosis tipo 0.50222 von recklinghausen 0.491269 estadios ia 0.468147 vía oral 0.457153 estadio il 0.488391 rayos x 0.474452 único tratamiento 0.566108 estadio ib 0.532006 menor cantidad 0.562912 estadio ia 0.530637 carcinoma nevoide 0.493219 National Cancer Institute 0.451467 siguientes riesgos 0.443955 Instituto Nacional 0.590522	PDQ Tratamiento 0.505529 alta potencia 0.472015 estadio iia 0.534137 presente sección 0.449331 tumor haces estrechos 0.590695 Drugs Approved 0.457515 partes distantes 0.468081 Physician Data Query 0.588152 Soft Tissue Sarcoma 0.634121 radioterapia externa causa 0.549798 adultos causa efectos 0.535671 área enteras 0.486295 siguientes enlaces 0.454055 siguientes pruebas 0.644136 siguientes sumarios 0.574908 siguientes estadios 0.500903 siguientes trastornos 0.524918	CLICK HERE
3669	National Cancer Institute	Html	en	Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer	The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.	cancer prevention trials 0.416255 Rosalind A. Eeles 0.411778 surgical treatment 0.379516 estrogen-alone hormone replacement 0.439159 HRT 0.650737 control group 0.489038 HRT group 0.449172 ovarian function 0.415733 menopausal symptoms 0.542367 relapse-free survival 0.465056 Cancer Therapy Evaluation 0.421244 overall survival 0.581691 ovarian estrogen 0.432665 ovarian cancer 0.928941 ovarian cancer experience 0.492272 patients 0.45695 randomized clinical trial 0.43176 Elise C. Kohn 0.397302 adjuvant therapy 0.381362 standard treatment options 0.433426 median estimated time 0.405984 main secondary endpoint 0.410696 survival outcomes 0.37806 hormone therapy group 0.578064 mean overall survival 0.423556	potentially relevant factors 0.394794 hormone replacement therapy 0.634279 Hormone Therapy trial 0.447307 hormone therapy groups 0.42905 ovarian cancer treatment 0.476999 treatment groups 0.365534 women 0.520693 mean relapse-free survival 0.417235 random assignment 0.405372 comfortable offering patients 0.408947 additional health benefits 0.409837 adverse health effects 0.418883 Cancer Research 0.418301 severe menopausal symptoms 0.511618 epithelial ovarian cancer 0.775578 postmenopausal women 0.378934 trial results 0.36603 breast cancer 0.41792 transient ischemic attack 0.398107 treatment effects 0.367465 study authors 0.552833 Premenopausal women 0.389334 similar survival 0.379958 statistically significant differences 0.397215	CLICK HERE